Stockreport

Werewolf Therapeutics GAAP EPS of -$0.38 beats by $0.07 Nov. 08, 2024 2:25 AM ET By: Manshi Mamtora , CFA [Seeking Alpha]

Werewolf Therapeutics, Inc.  (HOWL) 
PDF As of September 30, 2024, cash and cash equivalents were $122.8 million, compared to $135.3 million as of June 30, 2024. More on Werewolf Therapeutics Seeking Alpha [Read more]